The trademark Zimara was filed by Meda AB, a corporation established under the laws of the Kingdom of Sweden (the "Applicant"). The application was published for oppositions on June 20, 2011, and received undefined oppositions.
There are undefined Oppositions claimed against trademark.
The first opposition filed on September 20, 2011 by CSL Behring L.L.C. on Likelihood of confusion. the opponent was represented by BEST RECHTSANWÄLTE PARTMBB and its proceedings were handled in English The second opposition filed on September 20, 2011 by ALLERGAN, INC. on Likelihood of confusion. the opponent was represented by CARPMAELS & RANSFORD LLP and its proceedings were handled in English The third opposition filed on September 18, 2011 by Novartis AG on Likelihood of confusion. the opponent was represented by FRIEDRICH GRAF VON WESTPHALEN & PARTNER MBB and its proceedings were handled in English
The application was filed in English, and English was also language of all opposition proceedings (German was selected as the second language).
The renewal of the trademark was recorded by the office on March 7, 2021.
Change of name and address of the trademark registration was recorded on September 4, 2011. Appointment and Replacement of representative of the trademark registration was recorded on January 25, 2012. Appointment and Replacement of representative of the trademark registration was recorded on November 8, 2012. Appointment and Replacement of representative of the trademark registration was recorded on November 26, 2018.
The Appeal with reference B R0636/2014-5 was Opposition rejected according to Rule 22 CTMIR with decision issued on March 5, 2015 by the EUIPO. The Appeal with reference B R0175/2018-4 was Opposition rejected according to Article 8(1)(b) EUTMR with decision issued on February 18, 2018 by the EUIPO. The Opposition with reference B 001900706 was rejected according to Article 8(1)(b) CTMR with decision issued on January 8, 2014 by the EUIPO. The null with reference B T-238/15 was Decision partially annulled according to Article 8(1)(b) EUTMR with decision issued on September 20, 2017 by the EUIPO.